Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 762 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	PharmacoEconomic Assessment IRESSA® in the Treatment of Non–Small-Cell Lung Cancer (NSCLC)				Phase IV				9461700718 NCT00173524
	"Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer				Phase IV				2005-060-version1a NCT00338481
	A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)				Phase IV				AVF3991n NCT00388206
	Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)				Phase IV				D7913C00046 NCT00536107
	Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients				Phase IV				UMCN-AKF 07.02 EudraCTnr 2007-003347-73, NCT00588835
	Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice				Phase IV				PROLOG NCT00675168
	Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-Small-Cell Lung Cancer (NSCLC)				Phase IV				97-02-12 NCT00686322
	A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.				Phase IV				BO21015 2008-000662-23, NCT00700180
	Paclitaxel Plus Carboplatin With Endostar in Patients of Advanced Non-Small Cell Lung Cancer				Phase IV				XYL014 NCT00708812
	Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer				Phase IV				2612-3681 NCT00724581


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute